Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Rituximab-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rituximab 10mg/mL injection concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rituximab 10mg/mL infusion concentrate 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rituximab 500mg infusion concentrate vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rituximab 100mg infusion concentrate vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adverse reaction caused by rituximab administered by infusion (disorder) |
Causative agent (attribute) |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing rituximab in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
R-ICE chemotherapy regimen |
Direct substance |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
7 |
R-CHOP chemotherapy regimen |
Direct substance |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
6 |
Rituximab therapy (procedure) |
Direct substance |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely rituximab 100 milligram/10 milliliter conventional release solution for infusion vial |
Has basis of strength substance (attribute) |
False |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rituximab 100 milligram/10 milliliter conventional release solution for infusion vial |
Has precise active ingredient |
False |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rituximab 500 milligram/50 milliliter conventional release solution for infusion vial |
Has basis of strength substance (attribute) |
False |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rituximab 500 milligram/50 milliliter conventional release solution for infusion vial |
Has precise active ingredient |
False |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rituximab only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only rituximab in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy |
Direct substance |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Rituximab 10 mg/mL solution for injection |
Has precise active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rituximab 10 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rituximab 10 mg/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rituximab 10 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Rituximab (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |